NOC vs PRME · P/E 17, rev $20.76B vs rev $4.6M
Northrop Grumman Corporation (NOC) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. PRME currently screens at market cap $570.8M.
Not investment advice. Open the NOC and PRME stock pages for the full models.
Not investment advice.